cross-sex hormones

In this episode, pediatric endocrinologist Dr. Quentin Van Meter reveals the truth behind one of the most controversial practices in modern medicine: the use of puberty blockers and cross-sex hormones on children with sexual identity confusion. He also outlines the disturbing legacy of John Money, the man whose unethical experiments helped launch today’s gender ideology. With over four decades of clinical experience, including training at Johns Hopkins and service in the U.S. Navy, Dr. Van Meter explains how chemical and surgical interventions on children with sexual identity disorder swept through pediatrics despite a lack of scientific evidence, how clinics rapidly adopted irreversible interventions, and why so many doctors feel pressured to “affirm” rather than question. Dr. Van Meter shares: He Read More ›

The New England Journal of Medicine continues to besmirch its once august reputation by pushing ideology rather than medical science when discussing our nation’s most contentious social issues. This is particularly true about so-called gender-affirming care for minors experiencing gender confusion. Even as repeated medical studies undercut the ideological narrative that puberty blockers, hormones, and even surgeries are the best means of caring for dysphoric children — and as country after country severely restricted those interventions — (with the exception of an unsubstantive criticism of the Cass Review) articles in the NEJM on the question usually pretend that the pushback never happened.

Now, the editors have done it again, publishing an article by Scott Skinner-Thompson, an LGBT activist law professor from the University of Colorado, Boulder, criticizing the Supreme Court for allowing Tennessee to legally prevent such interventions in children. The pretense begins with the headline, “The Faulty Logic behind the Supreme Court’s Failure to Protect Trans Minors.” To the contrary, Tennessee and other jurisdictions that have enacted such laws have done so to protect trans minors from potentially irreversible harm, in the knowledge that most gender dysphoric minors overcome their confusion by the time they reach adulthood.

Then, Skinner-Thompson leans on clearly ideological opinions by medical associations, despite at least one of which (WPATH) having been substantively discredited:

On June 18, 2025, the U.S. Supreme Court upheld Tennessee’s ban on gender-affirming hormonal treatment for transgender minors against an Equal Protection Clause challenge in United States v. Skrmetti. Transgender adolescents who need these medical interventions but live in one of the many states that ban them may need to look elsewhere for care. Nearly every major relevant U.S. health care organization has concluded that the prescription of hormones and puberty blockers for treating gender dysphoria in transgender adolescents is often medically appropriate in that it can improve mental health and well-being, whereas untreated gender dysphoria can lead to depression, anxiety, and suicidality.